AH
Asima Health develops a non-invasive, multi-cancer blood test for early detection of various cancers. This pan-genomic platform simultaneously screens for multiple malignancies from a single blood draw, offering an accessible alternative to current invasive screening methods. The technology aims to quickly rule out cancer or identify individuals requiring follow-up diagnostics like colonoscopy or mammography.
Updated 20 months ago
Funding
$10K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
EWFunding rounds are not available yet.
Founders
Product
Features
- Asima Health develops a non-invasive, multi-cancer blood test for early detection of various cancers. This pan-genomic platform simultaneously screens for multiple malignancies from a single blood draw, offering an accessible alternative to current invasive screening methods. The technology aims to quickly rule out cancer or identify individuals requiring follow-up diagnostics like colonoscopy or mammography.